FREDUN.BO

Fredun Pharmaceuticals Limited

HealthcareMedical - PharmaceuticalsININRPeers →Country macro →

$2,308.85

Jun 05, 2026

AI Brief

Market cap

$12.64B

52w range

—

P / E

—

EPS · FY 2026

$61.23

Volume

—

Revenue · FY 2026

$6.39B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Fredun Pharmaceuticals Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$2308.85

Change

+48.79%

Period high

$2552.75

Period low

$1534.10

Period start

$1551.702026-02-01

Through 2026-06-05

Fair value

Football field →

Weighted blend

$1,345.31

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Consumer Defensive
+1.46%
Real Estate
+1.19%
Communication Services
+0.33%
Financial Services
+0.21%
Energy
+0.01%
Consumer Cyclical
-0.13%
Healthcare
-0.22%
Utilities
-0.29%
Industrials
-0.73%
Basic Materials
-1.36%
Technology
-3.71%

Top industries (issuer's industry highlighted)

Computer Hardware
-4.91%
Coal
-4.45%
Financial - Capital Markets
-4.33%
Information Technology Services
-3.97%
Industrial Materials
-3.52%
Travel Services
-3.50%
Semiconductors
-3.43%
Hardware, Equipment & Parts
-3.36%
Electronic Gaming & Multimedia
-3.33%
Software - Infrastructure
-3.30%
Apparel - Manufacturers
+3.21%
Copper
-3.02%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for FREDUN.BO.

Peers

No peer list available for FREDUN.BO.

Total assets

$6.42B

Total debt

$2.22B

Cash & equiv

$649.81M

Operating CF

$777.67M

Free cash flow

$41.76M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$6.39B	$862.94M	$326.21M	$61.23	+5.10%